1-204157117-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_000537.4(REN):​c.698+244T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0156 in 152,218 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.016 ( 31 hom., cov: 32)

Consequence

REN
NM_000537.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.89

Publications

1 publications found
Variant links:
Genes affected
REN (HGNC:9958): (renin) This gene encodes renin, an aspartic protease that is secreted by the kidneys. Renin is a part of the renin-angiotensin-aldosterone system involved in regulation of blood pressure, and electrolyte balance. This enzyme catalyzes the first step in the activation pathway of angiotensinogen by cleaving angiotensinogen to form angiotensin I, which is then converted to angiotensin II by angiotensin I converting enzyme. This cascade can result in aldosterone release, narrowing of blood vessels, and increase in blood pressure as angiotension II is a vasoconstrictive peptide. Transcript variants that encode different protein isoforms and that arise from alternative splicing and the use of alternative promoters have been described, but their full-length nature has not been determined. Mutations in this gene have been shown to cause hyperuricemic nephropathy familial juvenile 2, familial hyperproreninemia, and renal tubular dysgenesis. [provided by RefSeq, May 2020]
REN Gene-Disease associations (from GenCC):
  • familial juvenile hyperuricemic nephropathy type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0156 (2380/152218) while in subpopulation NFE AF = 0.0263 (1790/67996). AF 95% confidence interval is 0.0253. There are 31 homozygotes in GnomAd4. There are 1098 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 31 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000537.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
REN
NM_000537.4
MANE Select
c.698+244T>A
intron
N/ANP_000528.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
REN
ENST00000272190.9
TSL:1 MANE Select
c.698+244T>A
intron
N/AENSP00000272190.8
REN
ENST00000638118.1
TSL:5
c.584+244T>A
intron
N/AENSP00000490307.1

Frequencies

GnomAD3 genomes
AF:
0.0156
AC:
2379
AN:
152100
Hom.:
31
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00488
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00943
Gnomad ASJ
AF:
0.0135
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.0143
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0263
Gnomad OTH
AF:
0.0139
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0156
AC:
2380
AN:
152218
Hom.:
31
Cov.:
32
AF XY:
0.0148
AC XY:
1098
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.00486
AC:
202
AN:
41532
American (AMR)
AF:
0.00942
AC:
144
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
47
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4822
European-Finnish (FIN)
AF:
0.0143
AC:
152
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0263
AC:
1790
AN:
67996
Other (OTH)
AF:
0.0137
AC:
29
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
120
240
360
480
600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00765
Hom.:
0
Bravo
AF:
0.0147
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.19
DANN
Benign
0.55
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11571087; hg19: chr1-204126245; API